Steve Lock, PhD

Senior Marketing and Market Development Manager, Biopharma, EMEAI, SCIEX

Steve, a chartered chemist with a PhD in Physical Organic Chemistry, has over 20 years at SCIEX. Presenting at 80+ international meetings, he collaborates with biopharmaceutical industry customers and is an Adjunct Professor at the University of Pannonia.

Use of LC-MS in process analytical testing as part of development of a continuous manufacturing workflow

Daniel Myatt, Senior Scientist / Ronan Gough, Senior Scientist, CPI

Daniel, Biochemistry and Biophysics PhD, has extensive experience in biochemical and biophysical techniques across various sectors.

Ronan, holding a biochemistry PhD, focuses on the development of analytics for proteins and RNA, particularly by mass spectrometry and UPLC.

Developing methods for SEC-MS and IEX-MS for the analysis of biotherapeutics

Sarah Nguyen, PhD Student, Strasbourg University (LSMBO)

Sarah is pursuing a PhD in structural mass spectrometry to investigate primary and Higher Order Structure modifications associated with monoclonal antibodies variants.

Tips and tricks for biotherapeutics characterization by peptide mapping

Giulia Calloni, Senior Application Support Specialist, SCIEX

Giulia, with a PhD in Biochemistry, supports customers in the (bio)pharmaceutical industry with their LC-MS applications on both nominal and HR instruments.

The power of CZE analysis for characterization of NANOBODY® molecules

Dries Dejaegere, Senior Associate Scientist, Sanofi R&D Belgium

Dries specializes in Capillary Electrophoresis and MS analysis of NANOBODY® molecules, with a focus on advancing analytical methodologies.

Multi-capillary gel electrophoresis to increase throughput for the purity analysis of biotherapeutic proteins

Theresa Merlino, Senior Associate Scientist, The Janssen Pharmaceutical Companies of Johnson & Johnson

Theresa provides analytical support in early development, specializing in CE, liquid chromatography, and automation for higher throughput testing.

A disruptive approach to the characterization of mAb charge variants during biopharmaceutical process development

Greg Adams, Senior Director, Global Analytical Strategy & Development, FUJIFILM

Greg, a biotherapeutics expert with 30 years of experience, leads strategic projects to advance analytical service offerings and technologies.

Taylor dispersion analysis for health and biopharmaceutical analysis

Hervé Cottet, Professor, Montpellier University

Hervé, a full professor at IBMM, Montpellier, specializes in CE methodologies and Taylor Dispersion Analysis for characterizing biopharmaceuticals and polymers.

Tips and tricks for success in CE analysis

Whitney Smith, Senior Support Specialist CE, SCIEX

Whitney, PhD in analytical chemistry, supports CE applications with optical and mass spectrometric detection at SCIEX, showcasing dedication to advancing analytical methods.

Application of CE for purity analysis in cell and gene therapy

Ryan Hylands, Senior Technical Specialist / Luiza Chrojan, Scientific Associate II, Analytical Sciences, Pharmaron Gene Therapy

With over 15 years of Biopharma R&D experience, Ryan focuses on the development of HPLC and CE methods to support viral and plasmid analysis for AAV manufacture.

Luiza contributes to developing and validating CE applications within cell and gene therapy, emphasizing plasmid DNA and AAV.

RNA payload analysis: development and analytical challenges

Jérémie Parot, Research Scientist, SINTEF Industry

Jérémie focuses on physico-chemical characterization of nanodrug delivery systems, particularly RNA payload analysis and standardized methods.

The use of CE for AAV analytics

Padraig Flaherty, MSAT Analytical Development Scientist, MeiraGTx

Applying his biochemistry and cancer biology background, Padraig develops and validates assays for research, development, and quality control.

Oligo analysis by LC-MS

Alexandra Bushby, Method Development Chemist, Labcorp

Alexandra specializes in small molecule bioanalysis using LC-MS/MS. Currently pursuing a master's in biopharmaceutical development, she remains dedicated to advancing her knowledge.